esterbut-3: stabilizes butyric acid as a potent inhibitor of tumor cell proliferation in vivo; RN given refers to (alpha-D)-isomer; RN for cpd without isomeric designation not avail 7/91 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130381 |
| SCHEMBL ID | 8064634 |
| MeSH ID | M0188790 |
| Synonym |
|---|
| monobut-3 |
| 125161-47-9 |
| monoacetone glucose 3-butyrate |
| 3-o-butanoyl-1,2-o-isopropylidene-alpha-d-glucofuranose |
| esterbut-3 |
| alpha-d-glucofuranose, 1,2-o-(1-methylethylidene)-, 3-butanoate |
| 3n-butyrate |
| mag-3but |
| [(3ar,5r,6s,6ar)-5-[(1r)-1,2-dihydroxyethyl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-yl] butanoate |
| SCHEMBL8064634 |
| DTXSID40154677 |
| AKOS040746810 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||